Michael W. Kalb

Insider Reports History

Location
Dix Hills, NY
Signature
/s/ Michael W. Kalb
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael W. Kalb:

Company Role Class Num Shares Value Price $ Report Date Ownership
CATALYST PHARMACEUTICALS, INC. Executive Vice President & CFO Restricted Stock Units 632,903 $1,907,553 $4.01 05 Jan 2026 Direct
AMARIN CORP PLC\UK SVP and CFO Ordinary Shares 337,314 $367,672 $1.09 01 Aug 2022 Direct
CATALYST PHARMACEUTICALS, INC. Executive Vice President & CFO Common Stock, par value $0.001 per share 13,665 $318,942 $23.34 05 Jan 2026 Direct
CATALYST PHARMACEUTICALS, INC. Executive Vice President & CFO Options to purchase common stock 607,235 20 Nov 2025 Direct
IMPEL PHARMACEUTICALS INC CFO Stock Option (right to buy) 175,000 10 May 2023 Direct
AMARIN CORP PLC\UK SVP and CFO Restricted Stock Units 95,533 29 Jul 2022 Direct
IMPEL PHARMACEUTICALS INC CFO Restricted Stock Units (RSUs) 47,500 10 May 2023 Direct
CinCor Pharma, Inc. EVP & Chief Financial Officer Common Stock 0 $28.75 24 Feb 2023 Direct
CinCor Pharma, Inc. EVP & Chief Financial Officer Stock Option (Right to Buy) 0 24 Feb 2023 Direct
IMPEL PHARMACEUTICALS INC CFO No securities beneficially held. 0 10 May 2023 Direct

Insider Reports Filed by Michael W. Kalb

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CPRX CATALYST PHARMACEUTICALS, INC. 05 Jan 2026 3 $0 4 Executive Vice President & CFO 06 Jan 2026, 17:00
CPRX CATALYST PHARMACEUTICALS, INC. 20 Nov 2025 5 $0 4 Executive Vice President & CFO 24 Nov 2025, 20:08
CPRX CATALYST PHARMACEUTICALS, INC. 02 Jan 2025 3 $0 4 Executive Vice President & CFO 03 Jan 2025, 17:00
CPRX CATALYST PHARMACEUTICALS, INC. 21 Nov 2024 2 $0 4 Executive Vice President & CFO 25 Nov 2024, 17:01
CPRX CATALYST PHARMACEUTICALS, INC. 01 Jan 2024 0 $0 3 Executive Vice President & CFO 03 Jan 2024, 17:18
/report/000120919123029076-kalb-michael-wayne-2023-05-10 IMPEL PHARMACEUTICALS INC 10 May 2023 2 $0 4 CFO 12 May 2023, 16:41
/report/000120919123029044-kalb-michael-wayne-2023-05-10 IMPEL PHARMACEUTICALS INC 10 May 2023 0 $0 3 CFO 12 May 2023, 16:22
/report/000120919123012895-kalb-michael-wayne-2023-02-24 CinCor Pharma, Inc. 24 Feb 2023 2 $0 4 EVP & Chief Financial Officer 24 Feb 2023, 17:38
/report/000120919123005590-kalb-michael-wayne-2023-01-26 CinCor Pharma, Inc. 26 Jan 2023 1 $0 4 EVP & Chief Financial Officer 30 Jan 2023, 19:04
/report/000120919122056126-kalb-michael-wayne-2022-11-04 CinCor Pharma, Inc. 04 Nov 2022 2 $0 4 EVP & Chief Financial Officer 08 Nov 2022, 16:08
/report/000120919122056124-kalb-michael-wayne-2022-11-04 CinCor Pharma, Inc. 04 Nov 2022 0 $0 3 EVP & Chief Financial Officer 08 Nov 2022, 16:06
AMRN AMARIN CORP PLC\UK 29 Jul 2022 4 -$62,380 4 SVP and CFO 02 Aug 2022, 20:07
AMRN AMARIN CORP PLC\UK 28 Feb 2022 3 -$20,317 4 SVP and CFO 02 Mar 2022, 19:03
AMRN AMARIN CORP PLC\UK 04 Feb 2022 2 $0 4 SVP and CFO 08 Feb 2022, 19:05
AMRN AMARIN CORP PLC\UK 31 Jan 2022 3 -$17,865 4 SVP and CFO 02 Feb 2022, 19:03
AMRN AMARIN CORP PLC\UK 31 Dec 2021 3 -$85,020 4 SVP and CFO 04 Jan 2022, 20:08
AMRN AMARIN CORP PLC\UK 31 Aug 2021 7 -$16,681 4 SVP and CFO 02 Sep 2021, 20:04
AMRN AMARIN CORP PLC\UK 12 Aug 2021 5 -$348,440 4 SVP and CFO 13 Aug 2021, 20:04
AMRN AMARIN CORP PLC\UK 02 Aug 2021 1 $0 4 SVP and CFO 04 Aug 2021, 20:05
AMRN AMARIN CORP PLC\UK 30 Jul 2021 7 -$12,466 4 SVP and CFO 03 Aug 2021, 20:10
AMRN AMARIN CORP PLC\UK 30 Jun 2021 7 -$13,489 4 SVP and CFO 02 Jul 2021, 20:11
AMRN AMARIN CORP PLC\UK 28 May 2021 7 -$13,597 4 SVP and CFO 28 May 2021, 20:06